Iotim 0.5% Eye Drops 5ml

Fdc Ltd.

Bottle of 5 ML

MRP ₹75.04

₹61.53

₹15.01/ML

18% off applied
*MRP inclusive of all taxes
Get it By
Change
Choose your location

Use your current location

Login to view saved addresses

100% genuine medicines

Safe & secure payments

15 days Easy returns

Prescription required for this medicine

Store Below 30o C

About Iotim 0.5 % w/v Eye Drops

Iotim Eye Drops is a medicine used to manage elevated intraocular pressure in people with ocular hypertension or open-angle glaucoma. It helps reduce the risk of vision loss by lowering the pressure inside the eye.

This medicine is commonly used to control ocular hypertension and certain types of glaucoma. Ocular hypertension occurs when there is high fluid pressure inside the eye, while glaucoma causes damage to the optic nerve due to increased eye pressure.

To use Iotim Eye Drops, always wash your hands before applying them. Follow your doctor's prescribed dosage and avoid touching the dropper tip or bottle with anything to prevent infection. If you have any questions or concerns about potential side effects or your treatment plan, don't hesitate to discuss them with your doctor.

Last Updated On 04 Sep. 2023 | 1:06PM (IST)

Certified Content

Written by

Bhavya Mehta
Bhavya Mehta

Scientific & Medical Writer | 3 years

M.Sc. Biological Sciences

Reviewed by

Dr. Pauravi Abad
Dr. Pauravi Abad

Medical Writer & Reviewer | 4 years

MBBS

Check out Editorial Policy

References

  • Boyd, K., & McKinney, J. K. (2022). What Is Ocular Hypertension? Retrieved May 17, 2022, from https://www.aao.org/eye-health/diseases/what-is-ocular-hypertension
  • Barnes, J., & Moshirfar, M. (2021). Timolol. In StatPearls [Internet]. StatPearls Publishing. Retrieved May 17, 2022, from https://www.ncbi.nlm.nih.gov/books/NBK545176/
  • Bausch & Lomb Incorporated. (2013). Timolol. U.S. Food & Drug Administration. Retrieved May 17, 2022, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021516s005lbl.pdf
  • Kass, M. A., Gordon, M. O., Hoff, M. R., Parkinson, J. M., Kolker, A. E., Hart, W. M., & Becker, B. (1989). Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals: a randomized, double-masked, long-term clinical trial. Archives of ophthalmology, 107(11), 1590-1598.
  • Shojaei, A., Eslani, M., Vali, Y., Mansouri, M., Dadman, N., & Yaseri, M. (2012). Effect of timolol on refractive outcomes in eyes with myopic regression after laser in situ keratomileusis: a prospective randomized clinical trial. American Journal of Ophthalmology, 154(5), 790-798.
Was this product description useful?
29 people find this information helpful

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.

Subscribe

Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.

Download Truemeds

Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.

playstoreIcon

Contact Us

Our customer representative team is available 7 days a week from 9 am - 9 pm.


v3.4.10

copyright2024 - Truemeds | All rights reserved

Our Payment Partners

paymentPartnerpaymentPartnerpaymentPartnerpaymentPartnerpaymentPartner
paymentPartnerpaymentPartnerpaymentPartnerpaymentPartner